NCT03395574View on ClinicalTrials.gov

Effect of Terlipressin on Cerebral Oxygen Saturation During Liver Transplantation

PHASE2CompletedINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

January 25, 2018

Primary Completion Date

November 25, 2018

Study Completion Date

November 25, 2018

Conditions
Terlipressin Adverse ReactionLiver Transplantation
Interventions
DRUG

Terlipressin

drug will be given after 30 minutes of induction of anesthesia

DRUG

Normal saline

drug will be given after 30 minutes as placebo in control group

Trial Locations (1)

Unknown

Kasr Alainy Hospital , Faculty of Medicine, Cairo

All Listed Sponsors
lead

Kasr El Aini Hospital

OTHER

NCT03395574 - Effect of Terlipressin on Cerebral Oxygen Saturation During Liver Transplantation | Biotech Hunter | Biotech Hunter